CapEx at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's capex?
- Charles River Laboratories (CRL) reported capex of $55.91M in Q1 2026.
- How has Charles River Laboratories's capex changed year-over-year?
- Charles River Laboratories's capex decreased by 5.8% year-over-year, from $59.32M to $55.91M.
- What is the long-term trend for Charles River Laboratories's capex?
- Over 4 years (2021 to 2025), Charles River Laboratories's capex has grown at a -1.1% compound annual growth rate (CAGR), from $228.77M to $219.15M.
- What does capex mean?
- Cash spent on purchasing or maintaining long-term physical assets.
- How do you interpret capex?
- High spending indicates growth investment, while low spending may indicate cost-cutting or a mature asset base.
- How does capex compare across companies?
- Essential for comparing capital intensity across peers in the same industry.